1 Min Read
* Co-Diagnostics, Inc. Reports Q3 financial results and updates corporate developments
* Co-Diagnostics Inc - qtrly loss per share $0.33 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.